A Retrospective Analysis of the Impact of HIV Infection on Outcomes of Locally Advanced Cervical Cancers Treated With Either Conventional or Hypofractionated Radiotherapy: The Uganda Experience.
Awusi KavumaIsrael LuutuSolomon KibuddeDaniel KanyikePublished in: JCO global oncology (2022)
For the treatment of LACC with known HIV serology, there was no significant statistical difference in terms of response, toxicity, and compliance between CFRT and HFRT. However, the difference in overall survival between HIV-negative and HIV-positive was significant.
Keyphrases
- hiv positive
- antiretroviral therapy
- locally advanced
- men who have sex with men
- hiv infected
- radiation therapy
- human immunodeficiency virus
- south africa
- hiv aids
- hiv testing
- rectal cancer
- squamous cell carcinoma
- neoadjuvant chemotherapy
- phase ii study
- early stage
- oxidative stress
- small cell lung cancer
- newly diagnosed
- hepatitis c virus
- combination therapy
- type diabetes
- young adults
- clinical trial
- lymph node
- free survival
- skeletal muscle
- weight loss
- replacement therapy